Borgeson Blake, a director at Recursion Pharmaceuticals, Inc. ($RXRX), sold shares on the open market four times in the last year, totaling $3.43 million. The most recent sale occurred on March 3, 2026. These sales rank 2,474th among 11,678 individual insiders by value, below the average of $8.6 million per insider and 6 transactions. Blake made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 170000 | $3.46 | 6,259,863.0000 | 514,895,802 | 2.64% | 0.03% |
| Feb. 3, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 220000 | $4.20 | 6,429,863.0000 | 514,895,802 | 3.31% | 0.04% |
| Jan. 6, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 220000 | $4.36 | 6,649,863.0000 | 514,895,802 | 3.20% | 0.04% |
| Dec. 2, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 220000 | $4.37 | 6,869,863.0000 | 514,895,802 | 3.10% | 0.04% |
| June 18, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | A | Class A Common Stock | 22016 | $0.00 | 7,089,863.0000 | 395,072,094 | 0.31% | 0.01% |
| June 18, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | A | Stock Option (Right to Buy) | 44031 | $0.00 | 44,031.0000 | 395,072,094 | 9999.99% | 0.01% |
| Jan. 2, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | A | Class A Common Stock | 1734 | $0.00 | 7,067,847.0000 | 0 | 0.02% | 0.00% |
| Nov. 12, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $7.64 | 7,066,113.0000 | 0 | 0.16% | 0.00% |
| Oct. 29, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $6.72 | 7,077,560.0000 | 0 | 0.16% | 0.00% |
| Oct. 15, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $6.67 | 7,089,007.0000 | 0 | 0.16% | 0.00% |
| Oct. 1, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | A | Class A Common Stock | 2026 | $0.00 | 7,100,454.0000 | 0 | 0.03% | 0.00% |
| Oct. 1, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $6.22 | 7,098,428.0000 | 0 | 0.16% | 0.00% |
| Sept. 17, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $6.84 | 7,109,875.0000 | 0 | 0.16% | 0.00% |
| Sept. 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $6.27 | 7,121,322.0000 | 0 | 0.16% | 0.00% |
| Aug. 20, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $7.12 | 7,132,769.0000 | 0 | 0.16% | 0.00% |
| Aug. 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $6.82 | 7,144,216.0000 | 0 | 0.16% | 0.00% |
| July 23, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $8.48 | 7,155,663.0000 | 0 | 0.16% | 0.00% |
| July 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $7.32 | 7,167,110.0000 | 0 | 0.16% | 0.00% |
| July 1, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | A | Class A Common Stock | 1441 | $0.00 | 7,178,557.0000 | 0 | 0.02% | 0.00% |
| June 25, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $9.51 | 7,177,116.0000 | 0 | 0.16% | 0.00% |
| June 11, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $8.45 | 7,188,563.0000 | 0 | 0.16% | 0.00% |
| June 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | A | Stock Option (Right to Buy) | 26193 | $0.00 | 26,193.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | A | Class A Common Stock | 13097 | $0.00 | 7,200,010.0000 | 0 | 0.18% | 0.00% |
| May 28, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $9.17 | 7,186,913.0000 | 0 | 0.16% | 0.00% |
| May 14, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 20054 | $10.12 | 7,198,360.0000 | 0 | 0.28% | 0.00% |
| April 30, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $7.95 | 7,218,414.0000 | 0 | 0.16% | 0.00% |
| April 16, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $7.66 | 7,229,861.0000 | 0 | 0.16% | 0.00% |
| April 2, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $8.82 | 7,241,308.0000 | 0 | 0.16% | 0.00% |
| March 19, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 20054 | $10.79 | 7,252,755.0000 | 0 | 0.28% | 0.00% |
| March 5, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 20054 | $12.06 | 7,272,809.0000 | 0 | 0.27% | 0.00% |
| Feb. 20, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 309 | $13.04 | 7,292,863.0000 | 0 | 0.00% | 0.00% |
| Feb. 20, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 19745 | $12.31 | 7,293,172.0000 | 0 | 0.27% | 0.00% |
| Feb. 6, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $9.30 | 7,312,917.0000 | 0 | 0.16% | 0.00% |
| Jan. 23, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 20054 | $10.58 | 7,324,364.0000 | 0 | 0.27% | 0.00% |
| Jan. 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 13751 | $13.81 | 7,344,418.0000 | 0 | 0.19% | 0.00% |
| Jan. 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 6303 | $13.21 | 7,358,169.0000 | 0 | 0.09% | 0.00% |
| Dec. 26, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 20054 | $10.63 | 7,364,472.0000 | 0 | 0.27% | 0.00% |
| Dec. 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $7.40 | 7,384,526.0000 | 0 | 0.15% | 0.00% |
| Nov. 28, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 11447 | $6.72 | 7,395,973.0000 | 0 | 0.15% | 0.00% |
| Nov. 14, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $6.32 | 7,407,420.0000 | 0 | 0.12% | 0.00% |
| Oct. 31, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $5.27 | 7,416,305.0000 | 0 | 0.12% | 0.00% |
| Oct. 17, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $6.58 | 7,425,190.0000 | 0 | 0.12% | 0.00% |
| Oct. 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $7.29 | 7,434,075.0000 | 0 | 0.12% | 0.00% |
| Sept. 19, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $8.36 | 7,442,960.0000 | 0 | 0.12% | 0.00% |
| Sept. 5, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $8.79 | 7,451,845.0000 | 0 | 0.12% | 0.00% |
| Aug. 22, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $8.91 | 7,460,730.0000 | 0 | 0.12% | 0.00% |
| Aug. 8, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 3272 | $11.75 | 7,469,615.0000 | 0 | 0.04% | 0.00% |
| Aug. 8, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 14498 | $11.03 | 7,472,887.0000 | 0 | 0.19% | 0.00% |
| June 29, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | G | Class A Common Stock | 14000 | $0.00 | 7,506,104.0000 | 0 | 0.19% | 0.00% |
| July 25, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 18719 | $14.61 | 7,487,385.0000 | 0 | 0.25% | 0.00% |
| July 11, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $6.89 | 7,520,104.0000 | 0 | 0.12% | 0.00% |
| June 27, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $7.39 | 7,528,989.0000 | 0 | 0.12% | 0.00% |
| June 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | A | Class A Common Stock | 12612 | $0.00 | 7,537,874.0000 | 0 | 0.17% | 0.00% |
| June 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | A | Stock Option (Right to Buy | 25224 | $0.00 | 25,224.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 15485 | $9.98 | 7,525,262.0000 | 0 | 0.21% | 0.00% |
| May 30, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $8.79 | 7,540,747.0000 | 0 | 0.12% | 0.00% |
| May 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $5.09 | 7,549,632.0000 | 0 | 0.12% | 0.00% |
| April 18, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $5.93 | 7,558,517.0000 | 0 | 0.12% | 0.00% |
| April 4, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $6.53 | 7,567,402.0000 | 0 | 0.12% | 0.00% |
| March 21, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $7.40 | 7,576,287.0000 | 0 | 0.12% | 0.00% |
| March 7, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $8.33 | 7,585,172.0000 | 0 | 0.12% | 0.00% |
| Feb. 21, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $7.73 | 7,594,057.0000 | 0 | 0.12% | 0.00% |
| Feb. 7, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $8.81 | 7,602,942.0000 | 0 | 0.12% | 0.00% |
| Jan. 24, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $8.71 | 7,611,827.0000 | 0 | 0.12% | 0.00% |
| Jan. 10, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | S | Class A Common Stock | 8885 | $7.69 | 7,620,712.0000 | 0 | 0.12% | 0.00% |
| Jan. 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Borgeson Blake | Director | A | Class A Common Stock | 1325 | $0.00 | 7,629,597.0000 | 0 | 0.02% | 0.00% |